Ginkgo (ptc) Limited - Net Worth and Insider Trading

Ginkgo (ptc) Limited Net Worth

The estimated net worth of Ginkgo (ptc) Limited is at least $3.6 Billion dollars as of 2024-06-21. Ginkgo (ptc) Limited is the 2301 Trustee of Luye Pharma Group Ltd and owns about 1,259,196,703 shares of Luye Pharma Group Ltd (HKSE:02186) stock worth over $3.6 Billion. Details can be seen in Ginkgo (ptc) Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ginkgo (ptc) Limited has not made any transactions after 2024-04-10 and currently still holds the listed stock(s).

Transaction Summary of Ginkgo (ptc) Limited

To

Ginkgo (ptc) Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ginkgo (ptc) Limited owns 1 companies in total, including Luye Pharma Group Ltd (HKSE:02186) .

Click here to see the complete history of Ginkgo (ptc) Limited’s form 4 insider trades.

Insider Ownership Summary of Ginkgo (ptc) Limited

Ticker Comapny Transaction Date Type of Owner
HKSE:02186 Luye Pharma Group Ltd 2024-04-10 2301 Trustee

Ginkgo (ptc) Limited Latest Holdings Summary

Ginkgo (ptc) Limited currently owns a total of 1 stock. Ginkgo (ptc) Limited owns 1,259,196,703 shares of Luye Pharma Group Ltd (HKSE:02186) as of April 10, 2024, with a value of $3.6 Billion.

Latest Holdings of Ginkgo (ptc) Limited

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02186 Luye Pharma Group Ltd 2024-04-10 1,259,196,703 2.84 3,576,118,637

Holding Weightings of Ginkgo (ptc) Limited


Ginkgo (ptc) Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Ginkgo (ptc) Limited has made a total of 12 transactions in Luye Pharma Group Ltd (HKSE:02186) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Luye Pharma Group Ltd is the sale of 0 shares on April 10, 2024, which brought Ginkgo (ptc) Limited around $0.

Insider Trading History of Ginkgo (ptc) Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ginkgo (ptc) Limited Trading Performance

GuruFocus tracks the stock performance after each of Ginkgo (ptc) Limited's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ginkgo (ptc) Limited is -16.72%. GuruFocus also compares Ginkgo (ptc) Limited's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ginkgo (ptc) Limited within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ginkgo (ptc) Limited's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ginkgo (ptc) Limited

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -22.49 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -27.47 LIMIT LIMIT LIMIT LIMIT LIMIT

Ginkgo (ptc) Limited Ownership Network

Ownership Network List of Ginkgo (ptc) Limited

No Data

Ownership Network Relation of Ginkgo (ptc) Limited

Insider Network Chart

Ginkgo (ptc) Limited Owned Company Details

What does Luye Pharma Group Ltd do?

Who are the key executives at Luye Pharma Group Ltd?

Ginkgo (ptc) Limited is the 2301 Trustee of Luye Pharma Group Ltd. Other key executives at Luye Pharma Group Ltd include 2201 Interest of corporation controlled by you UBS Group AG , 2201 Interest of corporation controlled by you Luye Life Sciences Group Ltd , and 2101 Beneficial owner LuYe Pharmaceutical Investment Co., Ltd. .

Luye Pharma Group Ltd (HKSE:02186) Insider Trades Summary

Over the past 18 months, Ginkgo (ptc) Limited made 10 insider transaction in Luye Pharma Group Ltd (HKSE:02186) with a net purchase of 2,000,000. Other recent insider transactions involving Luye Pharma Group Ltd (HKSE:02186) include a net sale of 73,433,500 shares made by UBS Group AG , a net purchase of 2,000,000 shares made by Liu Dianbo , and a net purchase of 2,000,000 shares made by Luye Pharma Holdings Ltd. .

In summary, during the past 3 months, insiders sold 0 shares of Luye Pharma Group Ltd (HKSE:02186) in total and bought 3,569,500 shares, with a net purchase of 3,569,500 shares. During the past 18 months, 77,003,000 shares of Luye Pharma Group Ltd (HKSE:02186) were sold and 26,200,500 shares were bought by its insiders, resulting in a net sale of 50,802,500 shares.

Luye Pharma Group Ltd (HKSE:02186)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Luye Pharma Group Ltd Insider Transactions

No Available Data

Ginkgo (ptc) Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Ginkgo (ptc) Limited. Currently GuruFocus does not have mailing address information for Ginkgo (ptc) Limited.

Discussions on Ginkgo (ptc) Limited

No discussions yet.